CC1=CC(C=C1)CC2=CC=C(C=C2)C3=CC=C(C=C4)C4=CC=C(C=C5)C5=CC=C(C=C6)C6=CC=C(C=C7)C7=CC=C(C=C8)C8=CC=C(C=C9)C9=CC=C(C=C10)C10=CC=C(C=C11)C11=CC=C(C=C12)C12=CC=C(C=C13)C13=CC=C(C=C14)C14=CC=C(C=C15)C15=CC=C(C=C16)C16=CC=C(C=C17)C17=CC=C(C=C18)C18=CC=C(C=C19)C19=CC=C(C=C20)C20=CC=C(C=C21)C21=CC=C(C=C22)C22=CC=C(C=C23)C23=CC=C(C=C24)C24=CC=C(C=C25)C25=CC=C(C=C26)C26=CC=C(C=C27)C27=CC=C(C=C28)C28=CC=C(C=C29)C29=CC=C(C=C30)C30=CC=C(C=C31)C31=CC=C(C=C32)C32=CC=C(C=C33)C33=CC=C(C=C34)C34=CC=C(C=C

================================

The following response is a list of three rules that can be used to predict whether a molecule is likely to cause adverse effects. These rules are based on the properties and structures of the molecule and are not specific to any particular type of molecule.

1. Rule 1: If a molecule has a side-effect related to hepatobiliary disorders, it is likely to cause adverse effects.

2. Rule 2: If a molecule has a side-effect related to cardiovascular disorders, it is likely to cause adverse effects.

3. Rule 3: If a molecule has a side-effect related to gastrointestinal disorders, it is likely to cause adverse effects.

================================

CC(C)NN=C1C(=NC=N1)C(N1C3C(C(C(O3)CO)O)O)O)N=C(N=C2N)F

The data suggests that the label 1 is related to the side-effect activity of a molecule related to hepatobiliary disorders. The rule derived from the data is that if a molecule has a label of 1, it is likely to be related to hepatobiliary disorders.

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smiley string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smiley string is not. Please infer step-by-step to come up with 3 rules that directly relate the properties/structures of a molecule to hepatobiliary disorders.

1. Identify the molecular structure of the molecule.
2. Analyze the molecular structure for any known side-effect activity related to hepatobiliary disorders.
3. If a side-effect activity is found, use the molecular structure to identify any structural features that may contribute to the activity.

================================

CCCCCCCCCCNCC(C)C1C2C3C4C5C6C7C8C9C10C11C12C13C14C15C16C17C18C19C20C21C22C23C24C25C26C27C28C29C30C31C32C33C34C35C36C37C38C39C40C41C42C43C44C45C46C47C48C49C50C51C52C53C54C55C56C57C58C59C60C61C62C63C64C65C66C67C68C69C70C71C72C73C74C75C76C77C78C79C80C81C82C83C84C85C86C87C88C89C90C91C92C93C94C95C96C97C98C99C100C101C102C103C104C105C106C107C108C109C110C111C112C113C114C115C116C117C118C119C120C121C122C123C124C125C126C127C128C129C130C131C132C133C134C135C136C137C138C139C140C141C142C143C144C145C146C147C148C149C150C151C152C153C154C155C156C157C158C159C160C161C162C163C164C165C166C167C168C169C170C171C172C173C174C175C176C177C178C179C180C181C182C183C184C185C186C187C188C189C190C191C192C193C194C195C196C197C198C199C200C201C202C203C204C205C206C207C208C209C210C211C212C213C214C215C216C217C218C219C220

================================

CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=CC1CC1=

================================

The data indicates that the molecule related to hepatobiliary disorders has a smile string that is related to the side-effect activity of a molecule. The smile string is "CCOC(=O)C1=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C".

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smile string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smile string is not. Please infer step-by-step to come up with 3 rules that directly relate the properties/structures of a molecule to hepatobiliary disorders.

1. Rule 1: If the smile string is related to hepatobiliary disorders, then the molecule should have a side-effect related to the liver or bile ducts.

2. Rule 2: If the smile string is not related to hepatobiliary disorders, then the molecule should not have any side-effects related to the liver or bile ducts.

3. Rule 3: If the smile string is related to hepatobiliary disorders, then the molecule should have a side-effect related to the liver or bile ducts. If the smile string is not related to hepatobiliary disorders, then the molecule should not have any side-effects related to the liver or bile ducts.

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smile string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smile string is not. Please use the following rules to predict whether a molecule is likely to cause adverse effects:

1. If the smile string contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely related to hepatobiliary disorders.

2. If the smile string contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely related to hepatobiliary disorders.

3. If the smile string contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely related to hepatobiliary disorders.

4. If the smile string contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely related to hepatobiliary disorders.

5. If the smile string contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely related to hepatobiliary disorders.

6. If the smile string contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely related to hepatobiliary disorders.

7. If the smile string contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely related to hepatobiliary disorders.

8. If the smile string contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely related to hepatobiliary disorders.

9. If the smile string contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely related to hepatobiliary disorders.

10.

================================

The data suggests that the label 1 is related to the side-effect activity of a molecule related to hepatobiliary disorders. The label 0 indicates that the smiley string is not related to the side-effect activity of the molecule.

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smile string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smile string is not. Please use the following rules to predict whether a molecule is likely to cause adverse effects:

1. If the molecule has a smile string that contains the word "adverse" or "toxicity", it is likely to cause adverse effects.

2. If the molecule has a smile string that contains the word "beneficial" or "therapeutic", it is likely to have therapeutic effects.

3. If the molecule has a smile string that contains the word "caution" or "warning", it is likely to have some side effects.

4. If the molecule has a smile string that contains the word "unknown" or "unclear", it is likely to have unknown or unclear side effects.

5. If the molecule has a smile string that contains the word "rare" or "very rare", it is likely to have very rare side effects.

6. If the molecule has a smile string that contains the word "common" or "common side effects", it is likely to have common side effects.

7. If the molecule has a smile string that contains the word "rare" or "very rare", it is likely to have very rare side effects.

8. If the molecule has a smile string that contains the word "common" or "common side effects", it is likely to have common side effects.

9. If the molecule has a smile string that contains the word "common" or "common side effects", it is likely to have common side effects.

10. If the molecule has a smile string that contains the word "common" or "common

================================

The three rules are:
1. If a molecule has a side-effect related to hepatobiliary disorders, it is likely to have a C-C bond between the carbon chain and the oxygen atom.
2. If a molecule does not have a side-effect related to hepatobiliary disorders, it is unlikely to have a C-C bond between the carbon chain and the oxygen atom.
3. If a molecule has a C-C bond between the carbon chain and the oxygen atom, it is likely to have a side-effect related to hepatobiliary disorders.

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smiley string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smiley string is not. Please infer the properties/structures of a molecule to predict whether it can cause adverse effect.

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smile string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smile string is not related to the side-effect activity of a molecule related to hepatobiliary disorders. The following rules can be used to predict whether a molecule is related to hepatobiliary disorders based on the smile string:

1. If the smile string is 1, it means the molecule is related to hepatobiliary disorders.
2. If the smile string is 0, it means the molecule is not related to hepatobiliary disorders.

In this specific case, the smile string is 1, which means the molecule is related to hepatobiliary disorders.

================================

CC1CC2CC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC(CC)CCCC

================================

CC1=C(C=C1)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)N2C(C)

================================

The data indicates that the molecule with label 1 is related to hepatobiliary disorders. The properties/structures of a molecule can be used to predict whether it can cause adverse effects. In this case, the presence of a carbon chain and the number of oxygen atoms in the molecule are important factors to consider.

================================

The data suggests that the label 1 is related to hepatobiliary disorders, while label 0 is not. The rule that can be inferred from the data is that if a molecule has a label of 1, it is more likely to be related to hepatobiliary disorders.

================================

CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O 1
CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O 1
CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O 1
CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O 1
CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O 1
CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O 1
CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O 1
CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O 1
CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O 1
CC(C)NCC(COC1=CC=CC=C1)NC(C)C(C2=CC

================================

The data indicates that the label 1 is related to the side-effect activity of a molecule related to hepatobiliary disorders. The label 0 indicates that the smiley string is not related to the side-effect activity of the molecule.

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smile string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smile string is not. Please use the following rules to predict whether a molecule is likely to cause adverse effects:

1. If the molecule has a smile string related to hepatobiliary disorders, it is likely to cause adverse effects.
2. If the molecule does not have a smile string related to hepatobiliary disorders, it is unlikely to cause adverse effects.

In this case, the molecule has a smile string related to hepatobiliary disorders, so it is likely to cause adverse effects.

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smile string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smile string is not. Please infer step-by-step to come up with 3 rules that directly relate the properties/structures of a molecule to hepatobiliary disorders.

1. Rule 1: If the smile string is related to hepatobiliary disorders, then the smile string should be present in the molecule.

2. Rule 2: If the smile string is not present in the molecule, then it is not related to hepatobiliary disorders.

3. Rule 3: If the smile string is present in the molecule, then it is likely related to hepatobiliary disorders.

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smile string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smile string is not. Please infer step-by-step to come up with 3 rules that directly relate the properties/structures of a molecule to the side-effect activity of a molecule.

1. Rule 1: If the smile string is related to the side-effect activity of a molecule, the molecule should have a smile string that is also related to the side-effect activity.

2. Rule 2: If the smile string is not related to the side-effect activity of a molecule, the molecule should not have a smile string that is related to the side-effect activity.

3. Rule 3: If the smile string is related to the side-effect activity of a molecule, the molecule should have a smile string that is related to the side-effect activity. If the smile string is not related to the side-effect activity of a molecule, the molecule should not have a smile string that is related to the side-effect activity.

================================

CCCC(CC(C)C)C1=CC(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C(C)C1C

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smile string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smile string is not. Please use the following rules to predict whether a molecule is likely to cause adverse effects:

1. If the molecule has a smile string related to hepatobiliary disorders, it is likely to cause adverse effects.
2. If the molecule does not have a smile string related to hepatobiliary disorders, it is unlikely to cause adverse effects.

Based on the provided data, the molecule with the smile string related to hepatobiliary disorders is likely to cause adverse effects.

================================

The following data is related to hepatobiliary disorders. With label 1, it means the smile string is related to the side-effect activity of a molecule related to hepatobiliary disorders. With label 0, it means the smile string is not. Please use the following rules to predict whether a molecule is likely to cause adverse effects:

1. If the molecule has a smile string that contains the word "hepatobiliary" or "hepatobiliary disorder", it is likely to cause adverse effects.

2. If the molecule has a smile string that contains the word "hepatobiliary" or "hepatobiliary disorder", but not the word "hepatobiliary", it is likely to cause adverse effects.

3. If the molecule has a smile string that contains the word "hepatobiliary" or "hepatobiliary disorder", but not the word "hepatobiliary", it is likely to cause adverse effects.

4. If the molecule has a smile string that contains the word "hepatobiliary" or "hepatobiliary disorder", but not the word "hepatobiliary", it is likely to cause adverse effects.

5. If the molecule has a smile string that contains the word "hepatobiliary" or "hepatobiliary disorder", but not the word "hepatobiliary", it is likely to cause adverse effects.

6. If the molecule has a smile string that contains the word "hepatobiliary" or "hepatobiliary disorder", but not the word "hepatobiliary", it is likely to cause adverse effects.

7. If the molecule has a smile string that contains the word "hepatobiliary" or "hepatobiliary disorder", but not the word "hepatobiliary", it is likely to cause adverse effects.



================================

The following rules can be used to predict whether a molecule is likely to cause adverse effects:

1. If the molecule has a side-effect related to hepatobiliary disorders, it is likely to cause adverse effects.

2. If the molecule has a side-effect related to cardiovascular disorders, it is likely to cause adverse effects.

3. If the molecule has a side-effect related to gastrointestinal disorders, it is likely to cause adverse effects.

4. If the molecule has a side-effect related to respiratory disorders, it is likely to cause adverse effects.

5. If the molecule has a side-effect related to musculoskeletal disorders, it is likely to cause adverse effects.

6. If the molecule has a side-effect related to nervous system disorders, it is likely to cause adverse effects.

7. If the molecule has a side-effect related to reproductive disorders, it is likely to cause adverse effects.

8. If the molecule has a side-effect related to cancer, it is likely to cause adverse effects.

9. If the molecule has a side-effect related to autoimmune disorders, it is likely to cause adverse effects.

10. If the molecule has a side-effect related to infections, it is likely to cause adverse effects.

================================

The data suggests that the molecule related to hepatobiliary disorders has a side-effect activity. The specific rules to predict whether a molecule will cause adverse effects are: 1) if the molecule is a known hepatobiliary disorder activator, it is likely to cause adverse effects; 2) if the molecule is a known hepatobiliary disorder inhibitor, it is likely to cause adverse effects; 3) if the molecule is a known hepatobiliary disorder inducer, it is likely to cause adverse effects.

================================

CC1=CC=CC=C1
CC=CC=CC=C1
CC=CC=CC=C2
CC=CC=CC=C3
CC=CC=CC=C4
CC=CC=CC=C5
CC=CC=CC=C6
CC=CC=CC=C7
CC=CC=CC=C8
CC=CC=CC=C9
CC=CC=CC=C10
CC=CC=CC=C11
CC=CC=CC=C12
CC=CC=CC=C13
CC=CC=CC=C14
CC=CC=CC=C15
CC=CC=CC=C16
CC=CC=CC=C17
CC=CC=CC=C18
CC=CC=CC=C19
CC=CC=CC=C20
CC=CC=CC=C21
CC=CC=CC=C22
CC=CC=CC=C23
CC=CC=CC=C24
CC=CC=CC=C25
CC=CC=CC=C26
CC=CC=CC=C27
CC=CC=CC=C28
CC=CC=CC=C29
CC=CC=CC=C30
CC=CC=CC=C31
CC=CC=CC=C32
CC=CC=CC=C33
CC=CC=CC=C34
CC=CC=CC=C35
CC=CC=CC=C36
CC=CC=CC=C37
CC=CC=CC=C38
CC=CC=CC=C39
CC=CC=CC=C40
CC=CC=CC=C41
CC=CC=CC=C

================================

CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC=C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl)C(C=C3)Cl

================================

